Genetic modification of the association of paraquat and Parkinson's disease

Movement Disorders

Volumn 27, Issue 13, 2012, Pages 1652-1658

  Goldman, Samuel M ^a   Kamel, Freya ^b   Ross, G Webster ^c   Bhudhikanok, Grace S ^a   Hoppin, Jane A ^b   Korell, Monica ^a   Marras, Connie ^d   Meng, Cheryl ^a   Umbach, David M ^b   Kasten, Meike ^e   Chade, Anabel R ^f   Comyns, Kathleen ^a   Richards, Marie B ^g   Sandler, Dale P ^b   Blair, Aaron ^h   Langston, J William ^a   Tanner, Caroline M ^a  

^a PARKINSON S INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF LÜBECK   (Germany)

^f FAVALORO UNIVERSITY   (Argentina)

^g WESTAT   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gene environment interaction; Glutathione transferase; Paraquat; Parkinson's disease; Pesticide

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PARAQUAT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PARKINSON DISEASE; PRIORITY JOURNAL; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE SUSCEPTIBILITY; FEMALE; GENE DELETION; GENETIC ASSOCIATION STUDIES; GENOTYPE; GLUTATHIONE TRANSFERASE; HERBICIDES; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PARAQUAT; PARKINSON DISEASE, SECONDARY; QUESTIONNAIRES; RISK FACTORS;

EID: 84870356697     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25216     Document Type: Article

References (75)

1. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003; 53(Suppl 3): S26-S36; discussion, S36-S28.
2. Chinta SJ, Andersen JK. Redox imbalance in Parkinson's disease. Biochim Biophys Acta 2008; 1780: 1362-1367.
3. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 2008; 1147: 93-104.
4. Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010; 16: 653-661.
5. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008; 4: 600-609.
6. Tanner CM. Etiology: the role of environment and genetics. In: Factor SA, Weiner WJ, eds. Parkinson's Disease: Diagnosis and Clinical Management, 2nd ed. New York, NY: Demos; 2008: 387-405.
7. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology 2000; 21: 435-440.
8. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson's disease-is there a link? Environ Health Perspect 2006; 114: 156-164.
9. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 2011; 119: 866-872.
10. Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem 2002; 277: 1641-1644.
11. McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, Di Monte DA. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem 2005; 93: 1030-1037.
12. Ossowska K, Wardas J, Smialowska M, et al. A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease? Eur J Neurosci 2005; 22: 1294-1304.
13. Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000; 463: 247-283.
14. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88.
15. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997; 324: 25-28.
16. Dagnino-Subiabre A, Cassels BK, Baez S, Johansson AS, Mannervik B, Segura-Aguilar J. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem Biophys Res Commun 2000; 274: 32-36.
17. Juronen E, Tasa G, Uuskula M, Pooga M, Mikelsaar AV. Purification, characterization, and tissue distribution of human class theta glutathione S-transferase T1-1. Biochem Mol Biol Int 1996; 39: 21-29.
18. Diedrich A, Bock HC, Konig F, et al. Expression of glutathione S-transferase T1 (GSTT1) in human brain tumours. Histol Histopathol 2006; 21: 1199-1207.
19. Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res 1994; 54: 4920-4926.
20. Commandeur JN, Stijntjes GJ, Vermeulen NP. Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacol Rev 1995; 47: 271-330.
21. Prakasam A, Sethupathy S, Lalitha S. Plasma and RBCs antioxidant status in occupational male pesticide sprayers. Clin Chim Acta 2001; 310: 107-112.
22. Tomita M, Okuyama T, Katsuyama H, Ishikawa T. Paraquat-induced gene expression in rat kidney. Arch Toxicol 2006; 80: 687-693.
23. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001; 10: 1239-1248.
24. Kamel F, Tanner C, Umbach D, et al. Pesticide exposure and self-reported Parkinson's disease in the Agricultural Health Study. Am J Epidemiol 2007; 165: 364-374.
25. Alavanja MC, Sandler DP, McMaster SB, et al. The Agricultural Health Study. Environ Health Perspect 1996; 104: 362-369.
26. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
27. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992; 7: 2-13.
28. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994; 6: 45-58; discussion, 62.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
30. Abdel-Rahman SZ, El-Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996; 107: 229-233.
31. Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol 2009; 169: 756-760.
32. Ahmadi A, Fredrikson M, Jerregard H, et al. GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset. Biochem Biophys Res Commun 2000; 269: 676-680.
33. De Palma G, Dick FD, Calzetti S, et al. A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions. Mov Disord 2010; 25: 912-919.
34. Harada S, Fujii C, Hayashi A, Ohkoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 2001; 288: 887-892.
35. Dick FD, De Palma G, Ahmadi A, et al. Gene-environment interactions in parkinsonism and Parkinson's disease: the Geoparkinson study. Occup Environ Med 2007; 64: 673-680.
36. Perez-Pastene C, Graumann R, Diaz-Grez F, et al. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component. Neurosci Lett 2007; 418: 181-185.
37. Kelada SN, Stapleton PL, Farin FM, et al. Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease. Neurosci Lett 2003; 337: 5-8.
38. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 1999; 18: 141-145.
39. Biswas A, Sadhukhan T, Bose K, et al. Role of glutathione S-transferase T1, M1, and P1 polymorphisms in Indian Parkinson's disease patients. Parkinsonism Relat Disord 2012; 18: 664-665.
40. Rahbar A, Kempkes M, Muller T, et al. Glutathione S-transferase polymorphism in Parkinson's disease. J Neural Transm 2000; 107: 331-334.
41. Kiyohara C, Miyake Y, Koyanagi M, et al. GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson's disease in a Japanese population. Parkinsonism Relat Disord 2010; 16: 447-452.
42. van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000; 129: 61-76.
43. Karami S, Boffetta P, Rothman N, et al. Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis 2008; 29: 1567-1571.
44. Elbaz A, Levecque C, Clavel J, et al. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol 2004; 55: 430-434.
45. Wilk JB, Tobin JE, Suchowersky O, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology 2006; 67: 2206-2210.
46. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998; 352: 1344-1346.
47. Fong CS, Wu RM, Shieh JC, et al. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease. Clin Chim Acta 2007; 378: 136-141.
48. Manthripragada AD, Costello S, Cockburn MG, Bronstein JM, Ritz B. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology 2010; 21: 87-94.
49. Lock EA, Wilks MF. Paraquat. In: Krieger R, ed. Handbook of Pesticide Toxicology, 2nd ed. San Diego, CA: Academic; 2001: 1559-1603.
50. CDC. Facts About Paraquat [online]. Available at: http://www.bt.cdc.gov/agent/paraquat/basics/facts.asp. Accessed on February 20, 2012.
51. Hertzman C, Wiens M, Bowering D, Snow B, Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 1990; 17: 349-355.
52. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997; 48: 1583-1588.
53. Tanner CM, Ross GW, Jewell SA, et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch Neurol 2009; 66: 1106-1113.
54. Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov Disord 1994; 9: 69-75.
55. Firestone JA, Lundin JI, Powers KM, et al. Occupational factors and risk of Parkinson's disease: a population-based case-control study. Am J Ind Med 2010; 53: 217-223.
56. Bus JS, Gibson JE. Paraquat: model for oxidant-initiated toxicity. Environ Health Perspect 1984; 55: 37-46.
57. Franco R, Li S, Rodriguez-Rocha H, Burns M, Panayiotidis MI. Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson's disease. Chem Biol Interact 2010; 188: 289-300.
58. Czerniczyniec A, Karadayian AG, Bustamante J, Cutrera RA, Lores-Arnaiz S. Paraquat induces behavioral changes and cortical and striatal mitochondrial dysfunction. Free Radic Biol Med 2011; 51: 1428-1436.
59. Shimada H, Hirai K, Simamura E, et al. Paraquat toxicity induced by voltage-dependent anion channel 1 acts as an NADH-dependent oxidoreductase. J Biol Chem 2009; 284: 28642-28649.
60. Noriega GO, Gonzales S, Tomaro ML, Batlle AM. Paraquat-generated oxidative stress in rat liver induces heme oxygenase-1 and aminolevulinic acid synthase. Free Radic Res 2002; 36: 633-639.
61. Kang MJ, Gil SJ, Koh HC. Paraquat induces alternation of the dopamine catabolic pathways and glutathione levels in the substantia nigra of mice. Toxicol Lett 2009; 188: 148-152.
62. Kang MJ, Gil SJ, Lee JE, Koh HC. Selective vulnerability of the striatal subregions of C57BL/6 mice to paraquat. Toxicol Lett 2010; 195: 127-134.
63. Dinis-Oliveira RJ, Remiao F, Carmo H, et al. Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 2006; 27: 1110-1122.
64. Kuter K, Nowak P, Golembiowska K, Ossowska K. Increased reactive oxygen species production in the brain after repeated low-dose pesticide paraquat exposure in rats. A comparison with peripheral tissues. Neurochem Res 2010; 35: 1121-1130.
65. Bus JS, Cagen SZ, Olgaard M, Gibson JE. A mechanism of paraquat toxicity in mice and rats. Toxicol Appl Pharmacol 1976; 35: 501-513.
66. Kim JH, Gil HW, Yang JO, Lee EY, Hong SY. Effect of glutathione administration on serum levels of reactive oxygen metabolites in patients with paraquat intoxication: a pilot study. Korean J Intern Med 2010; 25: 282-287.
67. Hasegawa K, Miwa J. Genetic and cellular characterization of Caenorhabditis elegans mutants abnormal in the regulation of many phase II enzymes. PLoS One 2010; 5: e11194.
68. Alias Z, Clark AG. Studies on the glutathione S-transferase proteome of adult Drosophila melanogaster: responsiveness to chemical challenge. Proteomics 2007; 7: 3618-3628.
69. Yang W, Tiffany-Castiglioni E. The bipyridyl herbicide paraquat produces oxidative stress-mediated toxicity in human neuroblastoma SH-SY5Y cells: relevance to the dopaminergic pathogenesis. J Toxicol Environ Health A 2005; 68: 1939-1961.
70. Trinh K, Moore K, Wes PD, et al. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease. J Neurosci 2008; 28: 465-472.
71. Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, Pallanck LJ. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc Natl Acad Sci U S A 2005; 102: 8024-8029.
72. Rossjohn J, Board PG, Parker MW, Wilce MC. A structurally derived consensus pattern for theta class glutathione transferases. Protein Eng 1996; 9: 327-332.
73. Kodym R, Calkins P, Story M. The cloning and characterization of a new stress response protein. A mammalian member of a family of theta class glutathione S-transferase-like proteins. J Biol Chem 1999; 274: 5131-5137.
74. Blair A, Tarone R, Sandler D, et al. Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa. Epidemiology 2002; 13: 94-99.
75. Blair A, Thomas K, Coble J, et al. Impact of pesticide exposure misclassification on estimates of relative risks in the Agricultural Health Study. Occup Environ Med 2011; 68: 537-541.